<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Preconditioning the rat brain with spreading <z:hpo ids='HP_0000716'>depression</z:hpo> for 48 h induces potent ischemic tolerance (<z:mpath ids='MPATH_124'>infarct</z:mpath> tolerance) after an interval of 12-15 days, consequently reducing the infarcted lesion size in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase following focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, persistence of the morphological and functional neuroprotection has not yet been proven </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether tolerance-derived neuroprotection against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> persists or merely delays the progress of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Prolonged spreading <z:hpo ids='HP_0000716'>depression</z:hpo> was induced in mice by placing a depolarized focus with intracerebral microinfusion of <z:chebi fb="0" ids="32588">KCl</z:chebi> for 24 h; after intervals of 3, 6, 9 or 12 days, temporary focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was imposed </plain></SENT>
<SENT sid="4" pm="."><plain>In the analysis of the infarcted lesion volume 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, groups with 6 or 9 day interval demonstrated significantly smaller lesion volume compared to time-matched vehicle control group (P=0.002) </plain></SENT>
<SENT sid="5" pm="."><plain>Significant reduction in <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> was also observed at the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase, namely 14 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (33% reduction) (P=0.021) accompanied with less severe neurological deficits (38% reduction) (P=0.020) </plain></SENT>
<SENT sid="6" pm="."><plain>Using this technique, we also investigated if the mice with targeted disruption of a single BDNF allele (heterozygous BDNF-deficient mice) can gain the same potency of tolerance as the wild mice </plain></SENT>
<SENT sid="7" pm="."><plain>In the result on infarcted lesion volumes following temporary focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, potent tolerance developed in the <z:mp ids='MP_0002169'>wild type</z:mp> (35% reduction) (P=0.007) but not in the heterozygous BDNF-deficient mice (&lt;19% reduction) (P=0.155), indicating that BDNF expression level following spreading <z:hpo ids='HP_0000716'>depression</z:hpo> is contributing to <z:mpath ids='MPATH_124'>infarct</z:mpath> tolerance development </plain></SENT>
</text></document>